摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-Pentyl-isocapronsaeureamid | 100535-36-2

中文名称
——
中文别名
——
英文名称
N-Pentyl-isocapronsaeureamid
英文别名
4-methyl-N-pentylpentanamide
N-Pentyl-isocapronsaeureamid化学式
CAS
100535-36-2
化学式
C11H23NO
mdl
MFCD24388077
分子量
185.31
InChiKey
QNNGBKKDHOYCNA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    13
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.909
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    N-Pentyl-isocapronsaeureamid 在 lithium aluminium tetrahydride 作用下, 以 乙醚 为溶剂, 生成 Pentyl-isohexyl-amin
    参考文献:
    名称:
    A Study of the Formation of Haloamines and Cyclic Amines by the Free Radical Chain Decomposition of N-Haloammonium Ions (Hofmann-Löffler Reaction)1
    摘要:
    DOI:
    10.1021/ja01492a035
  • 作为产物:
    描述:
    参考文献:
    名称:
    A Study of the Formation of Haloamines and Cyclic Amines by the Free Radical Chain Decomposition of N-Haloammonium Ions (Hofmann-Löffler Reaction)1
    摘要:
    DOI:
    10.1021/ja01492a035
点击查看最新优质反应信息

文献信息

  • [EN] MACROCYCLIC COMPOUNDS FOR INHIBITION OF INHIBITORS OF APOPTOSIS<br/>[FR] COMPOSÉS MACROCYCLIQUES POUR L'INHIBITION D'INHIBITEURS DE L'APOPTOSE
    申请人:ENSEMBLE THERAPEUTICS
    公开号:WO2013071035A1
    公开(公告)日:2013-05-16
    The invention relates generally to macrocyclic compounds and their therapeutic use. More particularly, the invention relates to macrocyclic compounds that modulate the activity of inhibitors of apoptosis (IAPs) and/or are useful in the treatment of medical conditions, such as cancer.
    这项发明通常涉及大环化合物及其治疗用途。更具体地,该发明涉及调节凋亡抑制蛋白(IAPs)活性的大环化合物和/或用于治疗癌症等医疗状况的化合物。
  • CYCLOSPORIN CONJUGATES
    申请人:Selwood David
    公开号:US20120157385A1
    公开(公告)日:2012-06-21
    A conjugate which comprises a cyclosporin moiety of formula (I) linked to one or more mitochondrial targeting groups, or a pharmaceutically acceptable salt thereof: wherein: A represents or, B represents methyl or ethyl, one Of R 1 and R 1 represents hydrogen and the other represents methyl, R 2 represents ethyl or isopropyl, R 3 represents hydrogen or methyl, and R 4 represents —CH 2 CH(CH 3 )CH 3 , —CH 2 CH(CH 3 )CH 2 CH 3 , —CH(CH 3 )CH 3 or —CH(CH 3 )CH 2 CH 3 .
  • MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
    申请人:Arvinas Operations, Inc.
    公开号:US20220402907A1
    公开(公告)日:2022-12-22
    The present disclosure relates to bifunctional compounds, which find utility as modulators of Kirsten rat sarcoma protein (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation, accumulation, and/or overactivation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
  • [EN] RADIOPHARMACEUTICAL CONJUGATES TARGETING GUANYLYL CYCLASE C, AND COMPOSITIONS AND USES THEREOF<br/>[FR] CONJUGUÉS RADIOPHARMACEUTIQUES CIBLANT LA GUANYLYLE CYCLASE C, ET COMPOSITIONS ET UTILISATIONS DE CEUX-CI
    申请人:[en]RAYZEBIO, INC.
    公开号:WO2022115799A1
    公开(公告)日:2022-06-02
    Provided herein are radiopharmaceutical conjugate compositions and uses thereof. In one aspect, provided herein are conjugates that comprise a GCC binding peptide, a metal chelator configured to bind with a radionuclide, a linker that attaches the GCC binding peptide with the metal chelator, and optionally a radionuclide. Also provided herein are conjugates that have improved elimination profile and plasma stability that are suitable for radiopharmaceutical applications and methods of using the same in treating and/or diagnosing diseases such as cancer.
  • A Study of the Formation of Haloamines and Cyclic Amines by the Free Radical Chain Decomposition of N-Haloammonium Ions (Hofmann-Löffler Reaction)<sup>1</sup>
    作者:E. J. Corey、Walter R. Hertler
    DOI:10.1021/ja01492a035
    日期:1960.4
查看更多